Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2023, titled "Revision in Company s practice for making disclosures for product approvals".
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 17, 2023, titled "Revision in Company s practice for making disclosures for product approvals".